Does Radiofrequency Ablation Induce a Prethrombotic State? Analysis of Coagulation System Activation and Comparison to Electrophysiologic Study
SHARMILA DORBALA MBBS
St. Luke's-Roosevelt Hospital Center and Columbia University College of Physicians and Surgeons, New York, New York
Search for more papers by this authorALICE J. COHEN M.D.
St. Michael's Medical Center, Newark, New Jersey
Search for more papers by this authorLEIGH A. HUTCHINSON M.D.
St. Luke's-Roosevelt Hospital Center and Columbia University College of Physicians and Surgeons, New York, New York
Search for more papers by this authorEDITH MENCHAVEZ-TAN R.N., M.A.
St. Luke's-Roosevelt Hospital Center and Columbia University College of Physicians and Surgeons, New York, New York
Search for more papers by this authorCorresponding Author
JONATHAN S. STEINBERG M.D.
St. Luke's-Roosevelt Hospital Center and Columbia University College of Physicians and Surgeons, New York, New York
Address for correspondence: Jonathan S. Steinberg, M.D., Chief, Division of Cardiology, St. Luke's-Roosevelt Hospital Center, 1111 Amsterdam Avenue, New York, NY 10025. Fax: 212-523-3915; E-mail: [email protected].Search for more papers by this authorSHARMILA DORBALA MBBS
St. Luke's-Roosevelt Hospital Center and Columbia University College of Physicians and Surgeons, New York, New York
Search for more papers by this authorALICE J. COHEN M.D.
St. Michael's Medical Center, Newark, New Jersey
Search for more papers by this authorLEIGH A. HUTCHINSON M.D.
St. Luke's-Roosevelt Hospital Center and Columbia University College of Physicians and Surgeons, New York, New York
Search for more papers by this authorEDITH MENCHAVEZ-TAN R.N., M.A.
St. Luke's-Roosevelt Hospital Center and Columbia University College of Physicians and Surgeons, New York, New York
Search for more papers by this authorCorresponding Author
JONATHAN S. STEINBERG M.D.
St. Luke's-Roosevelt Hospital Center and Columbia University College of Physicians and Surgeons, New York, New York
Address for correspondence: Jonathan S. Steinberg, M.D., Chief, Division of Cardiology, St. Luke's-Roosevelt Hospital Center, 1111 Amsterdam Avenue, New York, NY 10025. Fax: 212-523-3915; E-mail: [email protected].Search for more papers by this authorAbstract
Ablation and Coagulation Activation. Introduction: Although thromboembolism is an uncommon complication of radiofrequency (RF) ablation, some preliminary reports have suggested that RF ablation results in activation of the coagulation system, possibly increasing this risk. We hypothesized that the insertion of intravenous catheters and their prolonged intravenous placement rather than RF ablation activates the coagulation cascade.
Methods and Results: Thirty-seven patients, group 1 (n = 21) during RF ablation, and group 2 (n = 16) during routine electrophysiologic studies (EPS), were studied prospectively. Blood was drawn for coagulation and fibrinolytic studies following insertion of venous sheaths (TO), following catheter placement (T1), and 1 hour after completion of RF ablation or EPS {T2). Conversion of prothrombin to thrombin was measured using thrombin-antithrombin complex (TAT) and prothrombin activation peptide (F1+2). and fibrinolytic activity was assessed using D-dlmer concentration. Levels of D-dimer increased in group 1 from 823.52 ± 323.52 ng/mL at TO to 1,314.28 ± 297.63 ng/mL at T2 (P= 0.005), and in group 2 from 658.15 ± 161.70 ng/mL at T0 to 1625 641.45 ng/mL at T2 (P=±0.064). TAT levels increased from to 27.74 ± 5.6 μg/L at T0 to 52.99 ± 5.93 μg/L at T2 in group 1 (P= 0.09), and from 19.79 ± 5.14 μg/L at T0 to 73.5 ± 24.15 μg/L at T2 in group 2 (P= 0.05). F1+2 concentration increased from 1.52 ± 0.30 nmol/L at T0 to 3.06 ± 0.41 nmol/L at T2 in group 1 (P= 0.004), and from 1.32 ± 0.30 nmol/L at T0 to 3.11 ± 0.46 nmol/L at T2 in group 2 (P= 0.087). There was no significant difference in the concentration of the three coagulation variables between group 1 and group 2 at any given time point. No correlation was demonstrable between concentration of D-dimers, TAT, or F1+2 and variables of RF delivery such as cumulative energy, number of RF energy applications, or number of impedance rises. However, a significant positive correlation (r = 0.65, P < 0.01) was noted between the duration of the RF ablation procedure and the concentration of D-dimers.
Conclusion: We conclude that activation of the coagulation cascade in RF ablation procedures is not related to the delivery of RF energy, but is related to the placement of intravascular catheters and to the duration of the ablation procedure.
References
- 1 D'Arsonval M: Action Physiologique des courants alternatifs. Comp Rend Soc Biol 1891; 43: 283.
- 2 Olgin JE, Scheinman MM: Comparison of high energy direct current and radiofrequency catheter ablation of atrioventricular junction. J Am Coll Cardiol 1993; 21: 557–564.
- 3 Evans G, Huang W, CAR Investigators: Comparison of direct current and radiofrequency energy for catheter ablation of atrioventricuiar junction: Results of a prospective multicenter study. Circulation 1990; 82(Suppl III): III–719.
- 4 Huang SKS, Graham AR, Lee MA, et al: Comparison of catheter ablation using radiofrequency versus direct current energy: Biophysical, electrophysiologic and pathologic observations. J Am Coll Cardiol 1991; 18: 1091–1099.
- 5 Huang SK, Bharati S, Graham AR, et al: Closed chest catheter dessication of atrioventricular junction using radiofrequency energy: A new method of catheter ablation. J Am Coll Cardiol 1987; 9: 349–358.
- 6 Langberg J, Lee M, Chin M, et al: Radiofrequency catheter ablation: The effect of electrode size on lesion volume in vivo. PACE 1990; 13: 1242–1248.
- 7 Langberg JJ, Chin M, Schamp DJ, et al: Ablation of the atrioventricular junction with radiofrequency energy using a new electrode catheter. Am J Cardiol 1991; 67: 142–147.
- 8 Blouin LT, Marcus Fl: The effect of electrode design on the efficacy of delivery of radiofrequency energy to cardiac tissue in vitro. PACE 1989; 12: 136–143.
- 9 Scheinman MM: North American Society of Pacing and Electrophysiology (NASPE) Survey on radiofrequency catheter ablation: Implications for clinicians, third party insurers, and government regulatory agencies. PACE 1992; 15: 2228–2231.
- 10 Thakur RK, Klein GJ, Yee R, et al: Complications of radiofrequency catheter ablation: A review. Can J Cardiol 1994; 10: 835–839.
- 11 Hindricks G, on behalf of the Multicentre European Radiofrequency Survey (MERES): Complications of radiofrequency ablation of arrhythmias. Eur Heart J 1993; 14: 1644–1653.
- 12 Thakur RK, Klein GJ, Yee R: Radiofrequency catheter ablation in patients with Wolff-Parkinson-White syndrome. Can Med Assoc J 1994; 151: 771–776.
- 13 Green TO, Huang SK, Wagshal AB, et al: Cardiovascular complications after radiofrequency catheter ablation of supraventricular tachyarrhythmias. Am J Cardiol 1994; 74: 615–617.
- 14 Epstein MR, Knapp LD, Martindill M, et al: Embolic complications associated with radiofrequency catheter ablation. Am J Cardiol 1996; 77: 655–658.
- 15 Thakur RK, Klein GJ: Embolic complications after radiofrequency catheter ablation. Am J Cardiol 1994; 74: 278–279.
- 16 Kunze KP, Schluter M, Costard A, et al: Right atrial thrombus formation after transvenous catheter ablation of atrioventricular node. J Am Coll Cardiol 1985; 6: 1428–1430.
- 17 Raitt MH, Schwaegler B, Pearlman AS, et al: Development of an aortic valve mass after radiofrequency catheter ablation. PACE 1993; 16: 2064–2066.
- 18 Tanno K, Kobayashi Y, Kurano K, et al: Histopathology of canine hearts subjected to catheter ablation using radiofrequency energy. Jpn Circ J 1994; 58: 123–135.
- 19 Kongsgaard E, Foester A, Aass H, et al: Power and temperature guided radiofrequency catheter ablation of the right atrium in pigs. PACE 1994; 17: 1610–1620.
- 20 Langberg J, Griffin JC, Herre JM, et al: Catheter ablation of accessory pathways using radiofrequency energy in canine coronary sinus. J Am Coll Cardiol 1989; 13: 491–496.
- 21 Wang TL, Lin JL, Hwang JJ, et al: The evolution of platelet aggregability in patients undergoing catheter ablation for supraventricular tachycardia with radiofrequency energy: The role of antiplatelet therapy. PACE 1995; 18: 1980–1990.
- 22 Boisclair MD, Philippou H, Lane DA: Thrombogenic mechanisms in the human: Fresh insights obtained by immunodiagnostic studies of coagulation markers. Blood Coagul Fibrinolysis 1993; 4: 1007–1021.
- 23 Rochemaure J, Laaban JP, Achkar A, et al: Value of determination of D-dimers in the diagnostic approach of venous thrombo-embolic disorders (French). Bull Acad Natl Med 1995; 179: 299–316.
- 24 Bauer KA, Weitz JI: Laboratory markers of coagulation and fibrinolysis. In RW Colman, et al, eds: Hemostasis and Thrombosis: Basic Principles and Clinical Practice. J.B. Lippincott Co., Philadelphia , 1994, pp. 1197–1210.
- 25 Boneu B, Bes G, Pelzer H, et al: D-dimers, thrombin antithrombin III complexes and prothrombin fragments 1+2: Diagnostic value in clinically suspected deep vein thrombosis. Thromb Haemost 1991; 65: 28–32.
- 26 Wilde JT, Kitchen S, Greaves M, et al: Plasma D-dimer levels and their relationship to serum fibrinogen/fibrin degradation products in hypercoagulable states. Br J Haematol 1989; 71: 65–70.
- 27 Teitl JM, Bauer KA, Lau HK, et al: Studies of the prothrombin activation pathway utilizing radioimmunoassay for the F2/F1+2 fragment and the thrombin-antithrombin complex. Blood 1982; 59: 1086–1097.
- 28 Shi Q, Ruiz JA, Perez LM, et al: Detection of prothrombin activation with a two-site enzyme immunoassay for the fragment F1+2. Thromb Haemost 1989; 62: 165.
- 29 Mannucci PM, Tripodi A, Botasso B, et al: Markers of procoagulant imbalance in patients with inherited thrombophilic syndromes. Thromb Haemost 1992; 67: 200–202.
- 30 Miake J, Igawa O, Tomokuni A, et al: Changes of coagulation and fibrinolysis after radiofrequency catheter ablation. (Abstract) Circulation 1994; 90: 1–606.
- 31
Giri S,
Berns E,
Lippman N, et al: Effectiveness of heparin for prevention of coagulation factor activation during radiofrequency catheter ablation. (Abstract) J Am Coll Cardiol
1995; 25: 361A.
10.1016/0735-1097(95)92954-4 Google Scholar
- 32 Manolis AS, Melita-Manolis H, Vassilikos V, et al: Thrombogenicity of radiofrequency lesions: Results with serial D-dimer determinations. J Am Coll Cardiol 1996; 28: 1257–1261.
- 33 Scheinman MM, Laks MM, DiMarco J, et al: Current role of catheter ablative procedures in patients with cardiac arrhythmias: A report for health professionals from the subcommittee on electrocardiography and electrophysiology. Circulation 1991; 83: 2146–2153.
- 34 Huang SKS: Advances in applications of radiofrequency current to catheter ablation therapy. PACE 1991; 14: 28–42.
- 35 Huang SKS: Radio-frequency catheter ablation of cardiac arrhythmias: Appraisal of an evolving therapeutic modality. Am Heart J 1989; 118: 1317–1323.
- 36 Haines DE, Watson DD, Verow AF: Electrode radius predicts lesion radiofrequency energy heating-validation of a proposed thermodynamic model. Circ Res 1990; 67: 124–129.
- 37 Haines DE, Verow AF: Observations on electrode tissue interface temperature and effect on electrical impedance during radiofrequency ablation of ventricular myocardium. Circulation 1990; 82: 1034–1038.
- 38
Haines DE: Determinants of lesion size during radiofrequency catheter ablation: The role of electrode-tissue contact pressure and duration of energy delivery.
J Cardiovasc Electrophysiol
1991; 2: 509–515.
10.1111/j.1540-8167.1991.tb01353.x Google Scholar
- 39 Haines DE: The biophysics of radiofrequency catheter ablation in the heart: The importance of temperature monitoring. PACE 1993; 16: 586–591.
- 40 Nath S, DiMarco JP, Haines DE: Basic aspects of radiofrequency catheter ablation. J Cardiovasc Electrophysiol 1994; 5: 863–876.
- 41 Jackman WM, Wang X, Friday KJ, et al: Catheter ablation of accessory atrioventricular pathways (Wolff-Parkinson–White syndrome) by radiofrequency current. N Engl J Med 1991; 324: 1605–1611.
- 42 Kuck KH, Schluter M, Geiger M, et al: Radiofrequency current catheter ablation of accessory atrioventricular pathways. Lancet 1991; 337: 1557–1561.
- 43 Lesh MD, Van Hare GF, Schamp DJ, et al: Curative percutaneous catheter ablation using radiofrequency energy for accessory pathways in all locations: Results in 100 consecutive patients. J Am Coll Cardiol 1992; 19: 1303–1309.
- 44 Schwartz JF, Tracy CM, Fletcher DR: Radiofrequency endocardial catheter ablation of accessory atrioventricular pathway atrial insertion. Circulation 1993; 87: 487–499.
- 45 Goli VD, Prasad R, Hamilton K, et al: Transesophageal echocardiographic evaluation for mural thrombus following radiofrequency catheter ablation of accessory pathways. PACE 1991; 14: 1992–1997.
- 46 Kugler JD, Danford DA, Deal BJ, et al: Radiofrequency catheter ablation for tachyarrhythmias in children and adolescents. N Engl J Med 1994; 330: 1481–1487.
- 47 Ott L, Astrup L, Jensen RH, et al: Assessment of D-dimer in plasma: Diagnostic value in suspected deep venous thrombosis of the leg. Acta Med Scand 1988; 224: 263.
- 48 Rowbotham BJ, Carroll P, Whitaker AN, et al: Measurement of crosslinked fibrin derivatives: Use in the diagnosis of venous thrombosis. Thromb Haemost 1987; 57: 59–61.
- 49 Guyton AC: Textbook of Medical Physiology. WB. Saunders Company, Philadelphia , 1991, pp. 390–399.
- 50 Manolis AS, Vassilikos V, Maonis TN, et al: Pretreatment with aspirin and ticlopidine confers lower thrombogenic potential of radiofrequency catheter ablation. Am J Cardiol 1997; 79: 494–497.